11-77201591-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000260.4(MYO7A):​c.4996A>T​(p.Ser1666Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.548 in 1,613,536 control chromosomes in the GnomAD database, including 246,230 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1666T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.59 ( 26742 hom., cov: 31)
Exomes 𝑓: 0.54 ( 219488 hom. )

Consequence

MYO7A
NM_000260.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 2.52

Publications

51 publications found
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
MYO7A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, PanelApp Australia
  • Usher syndrome type 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant nonsyndromic hearing loss 11
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.6471216E-6).
BP6
Variant 11-77201591-A-T is Benign according to our data. Variant chr11-77201591-A-T is described in ClinVar as Benign. ClinVar VariationId is 43269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.681 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO7ANM_000260.4 linkc.4996A>T p.Ser1666Cys missense_variant Exon 36 of 49 ENST00000409709.9 NP_000251.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO7AENST00000409709.9 linkc.4996A>T p.Ser1666Cys missense_variant Exon 36 of 49 1 NM_000260.4 ENSP00000386331.3
MYO7AENST00000458637.6 linkc.4882A>T p.Ser1628Cys missense_variant Exon 36 of 49 1 ENSP00000392185.2
MYO7AENST00000409619.6 linkc.4849A>T p.Ser1617Cys missense_variant Exon 37 of 50 1 ENSP00000386635.2
MYO7AENST00000458169.2 linkc.2422A>T p.Ser808Cys missense_variant Exon 16 of 29 1 ENSP00000417017.2
MYO7AENST00000670577.1 linkn.2836A>T non_coding_transcript_exon_variant Exon 19 of 32 ENSP00000499323.1

Frequencies

GnomAD3 genomes
AF:
0.587
AC:
89174
AN:
151850
Hom.:
26687
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.687
Gnomad AMI
AF:
0.487
Gnomad AMR
AF:
0.628
Gnomad ASJ
AF:
0.441
Gnomad EAS
AF:
0.472
Gnomad SAS
AF:
0.348
Gnomad FIN
AF:
0.627
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.546
Gnomad OTH
AF:
0.584
GnomAD2 exomes
AF:
0.550
AC:
136951
AN:
249010
AF XY:
0.535
show subpopulations
Gnomad AFR exome
AF:
0.688
Gnomad AMR exome
AF:
0.671
Gnomad ASJ exome
AF:
0.445
Gnomad EAS exome
AF:
0.488
Gnomad FIN exome
AF:
0.627
Gnomad NFE exome
AF:
0.550
Gnomad OTH exome
AF:
0.524
GnomAD4 exome
AF:
0.544
AC:
795340
AN:
1461568
Hom.:
219488
Cov.:
63
AF XY:
0.538
AC XY:
390875
AN XY:
727064
show subpopulations
African (AFR)
AF:
0.685
AC:
22926
AN:
33480
American (AMR)
AF:
0.664
AC:
29693
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.434
AC:
11335
AN:
26134
East Asian (EAS)
AF:
0.472
AC:
18756
AN:
39696
South Asian (SAS)
AF:
0.372
AC:
32043
AN:
86252
European-Finnish (FIN)
AF:
0.625
AC:
33333
AN:
53336
Middle Eastern (MID)
AF:
0.446
AC:
2573
AN:
5766
European-Non Finnish (NFE)
AF:
0.551
AC:
612747
AN:
1111822
Other (OTH)
AF:
0.529
AC:
31934
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
20795
41589
62384
83178
103973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17222
34444
51666
68888
86110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.588
AC:
89296
AN:
151968
Hom.:
26742
Cov.:
31
AF XY:
0.588
AC XY:
43660
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.687
AC:
28504
AN:
41474
American (AMR)
AF:
0.629
AC:
9613
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.441
AC:
1531
AN:
3468
East Asian (EAS)
AF:
0.472
AC:
2421
AN:
5134
South Asian (SAS)
AF:
0.348
AC:
1679
AN:
4818
European-Finnish (FIN)
AF:
0.627
AC:
6614
AN:
10550
Middle Eastern (MID)
AF:
0.490
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
0.546
AC:
37119
AN:
67924
Other (OTH)
AF:
0.582
AC:
1228
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1886
3772
5657
7543
9429
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
734
1468
2202
2936
3670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.544
Hom.:
17241
Bravo
AF:
0.596
TwinsUK
AF:
0.562
AC:
2085
ALSPAC
AF:
0.552
AC:
2126
ESP6500AA
AF:
0.681
AC:
2919
ESP6500EA
AF:
0.543
AC:
4591
ExAC
AF:
0.543
AC:
65799
Asia WGS
AF:
0.435
AC:
1515
AN:
3478
EpiCase
AF:
0.541
EpiControl
AF:
0.539

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 08, 2007
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 22, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 22, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25342930, 19320733, 21569298)

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Autosomal recessive nonsyndromic hearing loss 2 Benign:2
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.

Autosomal dominant nonsyndromic hearing loss 11 Benign:2
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.

Usher syndrome type 1 Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Usher syndrome type 1B Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.042
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
17
DANN
Benign
0.078
DEOGEN2
Benign
0.21
T;.;.;T
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.13
T;T;T;T
MetaRNN
Benign
0.0000066
T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-1.6
N;.;.;.
PhyloP100
2.5
PrimateAI
Benign
0.40
T
PROVEAN
Benign
5.5
N;N;N;N
REVEL
Benign
0.048
Sift
Benign
1.0
T;T;T;T
Sift4G
Benign
0.86
T;T;T;T
Vest4
0.23
ClinPred
0.0031
T
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.050
gMVP
0.32
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276288; hg19: chr11-76912636; COSMIC: COSV68684648; COSMIC: COSV68684648; API